Literature DB >> 17877511

Epidemiology of slow and fast colonic transit using a scale of stool form in a community.

R S Choung1, G R Locke, A R Zinsmeister, C D Schleck, N J Talley.   

Abstract

BACKGROUND: Measurement of gastrointestinal transit is commonly performed in the clinic, but data on transit in the community are lacking. AIM: To estimate the prevalence of slow and fast colonic transit using stool form, and potential risk factors.
METHODS: A validated self-reported gastrointestinal symptom questionnaire was mailed to 4196 randomly selected members of the community (response rate 54%). One question asked the subject to self-report their stool form using the Bristol Stool Scale.
RESULTS: Overall, 18%, 9% and 73% met stool form criteria for slow, fast or normal colonic transit, respectively. Increased odds for slow transit were observed with a higher Somatic Symptom Checklist score (OR = 1.6; 1.3-2.0), while a decreased odds for slow transit was observed in males relative to females (OR = 0.6; 0.5-0.8). An increased odds for fast transit was observed with higher Somatic Symptom Checklist score (OR = 2.3; 1.7-2.9) and a history of cholecystectomy (OR = 1.8; 1.2-2.8). Increasing body mass index (per 5 units) was associated with decreased odds for slow (OR = 0.85; 0.78-0.93), and an increased odds for fast (OR = 1.1; 1.04-1.24) colonic transit.
CONCLUSION: Based on stool form assessment, nearly one in five community members may have slow colonic transit and one in 12 have accelerated colonic transit.

Entities:  

Mesh:

Year:  2007        PMID: 17877511     DOI: 10.1111/j.1365-2036.2007.03456.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study.

Authors:  Uday C Ghoshal; Philip Abraham; Shobna J Bhatia; Sri Prakash Misra; Gourdas Choudhuri; K D Biswas; Karmabir Chakravartty; Sunil Dadhich; B D Goswami; V Jayanthi; Sunil Kumar; Abraham Koshy; K R Vinay Kumar; Govind Makharia; Sandeep Nijhawan; Nitesh Pratap; Gautam Ray; Sanjeev Sachdeva; Shivaram Prasad Singh; Varghese Thomas; Harsh Udawat
Journal:  Indian J Gastroenterol       Date:  2013-09-03

2.  Factors associated with persistent and nonpersistent chronic constipation, over 20 years.

Authors:  Rok Seon Choung; G Richard Locke; Enrique Rey; Cathy D Schleck; Charles Baum; Alan R Zinsmeister; Nicholas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

3.  Response to "A cross-sectional study of constipation and laxative use in advanced cancer patients: insights for revision of current practise".

Authors:  K Clark; D C Currow
Journal:  Support Care Cancer       Date:  2012-09-26       Impact factor: 3.603

4.  Prevalence and risk factors for abdominal bloating and visible distention: a population-based study.

Authors:  X Jiang; G R Locke; R S Choung; A R Zinsmeister; C D Schleck; N J Talley
Journal:  Gut       Date:  2008-06       Impact factor: 23.059

5.  Health care seeking for abdominal bloating and visible distention.

Authors:  X Jiang; G R Locke; A R Zinsmeister; C D Schleck; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2009-06-25       Impact factor: 8.171

Review 6.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

7.  The effects of ageing on the onset and disappearance of unexplained abdominal pain: a population-based study.

Authors:  R S Choung; G R Locke; C D Schleck; A R Zinsmeister; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2013-12-04       Impact factor: 8.171

8.  Validity of an observational assessment tool for multifaceted evaluation of faecal condition.

Authors:  Harumi Ohno; Haruka Murakami; Kumpei Tanisawa; Kana Konishi; Motohiko Miyachi
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

9.  No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.

Authors:  Luisa W Hugerth; Anna Andreasson; Nicholas J Talley; Anna M Forsberg; Lars Kjellström; Peter Thelin Schmidt; Lars Agreus; Lars Engstrand
Journal:  Gut       Date:  2019-10-10       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.